Anzeige
Mehr »
Login
Mittwoch, 04.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Analysten eilen, um Kursziele zu verdreifachen nach ATHAs neuester Entdeckung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 01.07.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
01.07.Voltalia and Taqa Arabia pursue the development of the cluster combining renewable energy generation with green hydrogen production in Egypt22Voltalia (Euronext Paris, ISIN code: FR0011995588), an international player in renewable energies, and its partner TAQA Arabia, signed a framework agreement during the Egypt-EU Investment Conference...
► Artikel lesen
01.07.Magle Chemoswed Holding AB: The acquisition of pK Biotech ApS and pK Chemicals A/S has been completed53Magle Chemoswed Holding AB ("Magle Group" or the "Company") has today acquired all shares in pK Biotech ApS ("pK Biotech") and its subsidiary pK Chemicals A/S ("pK Chemicals") in accordance with the...
► Artikel lesen
01.07.Lakeside Holding Limited Announces Closing Of Upsized $6.75 Million Initial Public Offering140Itasca, IL, July 01, 2024 (GLOBE NEWSWIRE) -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based integrated cross-border supply chain solution provider with a strategic...
► Artikel lesen
01.07.Vision Sensing Acquisition Corp. Announces Intention to Extend the Period to Consummate Its Initial Business Combination to August 3, 202481NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the "Company") a special purpose acquisition company, announced today that it has notified...
► Artikel lesen
01.07.HOOKIPA Pharma Inc.: HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV173Novel arenaviral therapeutic vaccine, developed in collaboration with Gilead Sciences, Inc. (Gilead), to be evaluated as a potential component of a curative regimen for human immunodeficiency virus...
► Artikel lesen
01.07.Solid Biosciences Inc.: Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)137CHARLESTOWN, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company"), a life sciences company developing precision genetic medicines for neuromuscular and cardiac...
► Artikel lesen
01.07.Codexis, Inc.: Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets109REDWOOD CITY, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into an asset purchase agreement with Crosswalk...
► Artikel lesen
01.07.Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)178BOSTON, July 01, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing...
► Artikel lesen
01.07.Bel Fuse Inc.: Bel Announces Retirement of Dennis Ackerman; Steve Dawson Appointed as President of Bel's Power and Protection Segment145WEST ORANGE, N.J., July 01, 2024 (GLOBE NEWSWIRE) -- Bel Fuse Inc. (Nasdaq: BELFA and BELFB) today confirmed consistent with prior announcements that Dennis Ackerman will retire from the Company effective...
► Artikel lesen
01.07.Versus Systems Inc.: Versus Systems Announces Strategic Restructuring, New Interim CEO, and Key Investor Engagement106VANCOUVER, British Columbia, July 01, 2024 (GLOBE NEWSWIRE) -- Versus Systems, Inc. (NASDAQ: VS), a pioneering technology company in interactive entertainment, is pleased to announce the appointment...
► Artikel lesen
01.07.Y-mAbs Therapeutics, Inc.: Y-mAbs Appoints Seasoned Biopharma Executive Peter Pfreundschuh as Chief Financial Officer63NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization...
► Artikel lesen
01.07.Roadzen Inc.: Roadzen Reports Record Revenue Growth in its First Fiscal Year as a Public Company68Full year revenue of $46.7 million, up from $13.5 million in the prior year, a 245% increase.Net loss of $99.7 million is impacted by non-cash, non-recurring and extraordinary items, resulting in...
► Artikel lesen
01.07.Tonner Drones: Results Annual General Meeting319Results Annual General MeetingCannes, 1-7-2024 Tonner Drones ("Tonner Drones" or the "Company") Announces Successful Annual General Meeting. At 3:00PM CET on Friday 28 June 2024, Tonner Drones held...
► Artikel lesen
01.07.TOYO Co., Ltd Announces Consummation of Business Combination and Debut on Nasdaq259Ordinary Shares of TOYO Co., Ltd to Trade on Nasdaq under the Ticker Symbol "TOYO" NEW YORK, NY, July 01, 2024 (GLOBE NEWSWIRE) -- TOYO Co., Ltd ("TOYO" or the "Company"), a solar solution company...
► Artikel lesen
01.07.Nasdaq, Inc.: Nasdaq Announces the Board of Directors of its U.S. Exchanges119NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today announced the election of all nominated directors to the boards of the U.S. exchanges operated by the company, which include...
► Artikel lesen
01.07.Goodness Growth Holdings Announces Name Change to Vireo Growth Inc.140- Subordinate voting shares expected to begin trading under new ticker symbols on July 8, 2024 - -Ticker symbol "VREO" on the CSE in Canada (CSE: VREO); "VREOF" on OTCQX Market (OTCQX: VREOF) - MINNEAPOLIS...
► Artikel lesen
01.07.Cryogenic Industries: Adrian Ridge Appointed CEO of Nikkiso Clean Energy & Industrial Gases Group322TEMECULA, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Effective July 1, 2024, Adrian Ridge is Chief Executive Officer of Nikkiso Clean Energy & Industrial Gases Group, part of Nikkiso Co. Ltd.'s...
► Artikel lesen
01.07.ADC Therapeutics SA: ADC Therapeutics Makes Grants to New Employees Under Inducement Plan315LAUSANNE, Switzerland, July 01, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that the Company has made grants of options to purchase an aggregate of 172,400 of the Company's...
► Artikel lesen
01.07.Golar LNG Limited - Q2 2024 results presentation357Golar LNG's 2nd Quarter 2024 results will be released before the NASDAQ opens on Thursday, August 15, 2024. In connection with this a webcast presentation will be held at 1:00 P.M We recommend that...
► Artikel lesen
01.07.Golar LNG: 2024 Annual General Meeting309Further to the press release of June 10, 2024 giving notice that the Golar LNG Limited 2024 Annual General Meeting will be held on August 13, 2024, a copy of the Notice of Annual General Meeting and...
► Artikel lesen
Seite:  Weiter >>